Sex and Body Mass Index differences in the incidence of vascular and cardiometabolic diseases: A retrospective cohort study including 233 730 patients in Germany.

IF 5.7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Ximena Orozco-Ruiz, Karel Kostev
{"title":"Sex and Body Mass Index differences in the incidence of vascular and cardiometabolic diseases: A retrospective cohort study including 233 730 patients in Germany.","authors":"Ximena Orozco-Ruiz, Karel Kostev","doi":"10.1111/dom.70104","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To examine the association between elevated body mass index (BMI) and a wide range of vascular and cardiometabolic diseases in men and women.</p><p><strong>Materials and methods: </strong>This retrospective cohort study used data from the IQVIA Disease Analyzer database, comprising anonymized records from over 3000 office-based physicians in Germany. We included 233 730 patients aged ≥40 years with at least one recorded BMI measurement between January 2005 and December 2023. Fourteen vascular and cardiovascular conditions were identified using ICD-10 codes. Ten-year cumulative incidence was estimated using the Kaplan-Meier method, and Cox regression models assessed associations between BMI groups and disease risk.</p><p><strong>Results: </strong>Obesity was associated with higher risks of heart failure (HR: 1.95; 95% CI: 1.85-2.05), pulmonary embolism (HR: 1.83; 95% CI: 1.62-2.07), atrial fibrillation/flutter (HR: 1.63; 95% CI: 1.55-1.72), phlebitis/vein thrombosis (HR: 1.60; 95% CI: 1.51-1.70), varicose veins of the lower extremities (HR: 1.57; 95% CI: 1.51-1.64), angina pectoris (HR: 1.30; 95% CI: 1.21-1.41), and myocardial infarction (HR: 1.26; 95% CI: 1.15-1.38), but a lower risk of haemorrhagic stroke (HR: 0.76; 95% CI: 0.62-0.93). Sex-specific analyses revealed stronger associations in men for heart failure, angina pectoris, and atrial fibrillation, while women showed stronger links to pulmonary embolism, phlebitis/vein thrombosis, myocardial infarction, and varicose veins. Notably, obesity was associated with a 26% lower risk of aortic aneurysm (thoracic or abdominal) in women, with no significant effect in men.</p><p><strong>Conclusions: </strong>Obesity is associated with an increased risk of vascular and cardiometabolic diseases. The strength and direction of associations show some variation between men and women, but these tendencies should be interpreted with caution.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.70104","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To examine the association between elevated body mass index (BMI) and a wide range of vascular and cardiometabolic diseases in men and women.

Materials and methods: This retrospective cohort study used data from the IQVIA Disease Analyzer database, comprising anonymized records from over 3000 office-based physicians in Germany. We included 233 730 patients aged ≥40 years with at least one recorded BMI measurement between January 2005 and December 2023. Fourteen vascular and cardiovascular conditions were identified using ICD-10 codes. Ten-year cumulative incidence was estimated using the Kaplan-Meier method, and Cox regression models assessed associations between BMI groups and disease risk.

Results: Obesity was associated with higher risks of heart failure (HR: 1.95; 95% CI: 1.85-2.05), pulmonary embolism (HR: 1.83; 95% CI: 1.62-2.07), atrial fibrillation/flutter (HR: 1.63; 95% CI: 1.55-1.72), phlebitis/vein thrombosis (HR: 1.60; 95% CI: 1.51-1.70), varicose veins of the lower extremities (HR: 1.57; 95% CI: 1.51-1.64), angina pectoris (HR: 1.30; 95% CI: 1.21-1.41), and myocardial infarction (HR: 1.26; 95% CI: 1.15-1.38), but a lower risk of haemorrhagic stroke (HR: 0.76; 95% CI: 0.62-0.93). Sex-specific analyses revealed stronger associations in men for heart failure, angina pectoris, and atrial fibrillation, while women showed stronger links to pulmonary embolism, phlebitis/vein thrombosis, myocardial infarction, and varicose veins. Notably, obesity was associated with a 26% lower risk of aortic aneurysm (thoracic or abdominal) in women, with no significant effect in men.

Conclusions: Obesity is associated with an increased risk of vascular and cardiometabolic diseases. The strength and direction of associations show some variation between men and women, but these tendencies should be interpreted with caution.

性别和身体质量指数在血管和心脏代谢疾病发病率中的差异:一项包括德国232330名患者的回顾性队列研究
目的:研究男性和女性身体质量指数(BMI)升高与多种血管和心脏代谢疾病之间的关系。材料和方法:本回顾性队列研究使用来自IQVIA疾病分析数据库的数据,包括来自德国3000多名办公室医生的匿名记录。我们纳入了232330例年龄≥40岁的患者,在2005年1月至2023年12月期间至少有一次BMI测量记录。使用ICD-10代码确定了14种血管和心血管疾病。使用Kaplan-Meier方法估计十年累积发病率,Cox回归模型评估BMI组与疾病风险之间的关联。结果:肥胖与心力衰竭(危险度:1.95;95% CI: 1.85-2.05)、肺栓塞(危险度:1.83;95% CI: 1.62-2.07)、心房颤动/颤振(危险度:1.63;95% CI: 1.55-1.72)、静脉炎/静脉血栓形成(危险度:1.60;95% CI: 1.51-1.70)、下肢静脉曲张(危险度:1.57;95% CI: 1.51-1.64)、心绞痛(危险度:1.30;95% CI: 1.21-1.41)和心肌梗死(危险度:1.26;95% CI: 1.15-1.38)的风险较高相关,但出血性中风(危险度:0.76;95% ci: 0.62-0.93)。性别特异性分析显示,男性与心力衰竭、心绞痛和心房颤动的相关性更强,而女性与肺栓塞、静脉炎/静脉血栓形成、心肌梗死和静脉曲张的相关性更强。值得注意的是,肥胖与女性患主动脉瘤(胸部或腹部)的风险降低26%有关,而对男性没有显著影响。结论:肥胖与血管和心脏代谢疾病的风险增加有关。这种联系的强度和方向在男性和女性之间有所不同,但这些趋势应该谨慎解释。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信